Supporting the superior toxicity of the complex, the in vitro cytotoxicity studies revealed more augmented anti-tumor effects for the NGR-CLB conjugate on B16F10 melanoma cells in comparison with solo CLB or NGR. Here, CLYBL is linked to melanoma.